We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Single-Cell Transcriptome Links Gut Development, Pediatric Crohn's Disease

By LabMedica International staff writers
Posted on 29 Dec 2020
Development of the human intestine is a highly complex process that requires synergy between a wide range of cell types. Importantly, environmentally triggered alterations in early development have been implicated in a range of immune-mediated pathologies, including inflammatory bowel diseases (IBD).

Furthermore, a number of studies have reported a link between early fetal intestinal epithelial cell dynamics and IBD suggesting that fetal-like transcriptional programs may re-appear in the intestinal epithelium of IBD patients. Hence, deciphering physiological intestinal development is a critical step toward prevention and treatment of such conditions.

A team of scientists affiliated with the Wellcome Sanger Institute (Wellcome Sanger Institute, Hinxton, UK) generated single-cell RNA-seq profiles for some 90,000 primary intestinal cells from nine fetal samples, seven pediatric Crohn's cases, and eight unaffected controls using the 10x Genomics Chromium platform (Pleasanton, CA, USA) and a Hi-seq 4000 sequencing (Illumina, San Diego, CA, USA).

The team, based on these, along with fetal organoid maturation and single-molecule fluorescence in situ hybridization experiments, identified intestinal cell populations that distinguish developing gut samples from those found in adults. In children with Crohn's disease, on the other hand, they saw epithelial cell activity by transcription factors that are normally limited to fetal roles. While stem cells in the adult gut are typically marked by enhanced expression of the stem cell marker Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5), for example, the team's single-cell profiles from embryonic and fetal cells spanning the first six to 10 weeks of development suggested that early epithelial precursor cells have characteristic and relatively consistent expression of a gene called BEX5.

With single-cell transcriptomes and other insights from maturing fetal organoid samples, meanwhile, the scientists got a look at the gene expression, regulation, and signaling shifts that accompany the maturation of intestinal epithelial cells from the stem cell stage to differentiated cell stages. Finally, when they set single-cell gene expression profiles from Crohn's disease cases and controls against available transcriptome data, the investigators saw signs that pediatric Crohn's disease may involve transcription factors that revert to enhanced activity levels found in fetal intestinal cells.

The authors concluded that IBD, and particularly Crohn's disease, are thought to be caused by a complex interplay between the environment and genetic predisposition leading to an irreversibly altered immune response. These latest results provide evidence in humans that regenerating Crohn's disease epithelium shares transcription factor programs otherwise present only in fetal epithelium. The study was published on December 7, 2020 in the journal Developmental Cell.

Related Links:
Wellcome Sanger Institute
10x Genomics
Illumina



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
High Performance Centrifuge
CO336/336R
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.